Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Toru Nakai"'
Autor:
Toru Nakai, Toshinaga Tsuji, Hiroshi Tsuda, Takuma Sotodate, Yuki Namba, Tatsuhiro Uenishi, Katsuhiko Iwasaki, Kinya Kokubo, Hiroaki Tomita
Publikováno v:
Neuropsychiatric Disease and Treatment.
Toru Nakai,1,* Toshinaga Tsuji,1,* Hiroshi Tsuda,2â 5 Takuma Sotodate,5 Yuki Namba,1 Tatsuhiro Uenishi,6 Katsuhiko Iwasaki,6 Kinya Kokubo,7,8 Hiroaki Tomita9 1Medical Affairs Department, Shionogi & Co., Ltd, Osaka, Japan; 2Clinical Resea
Autor:
Hisato Matsunaga, Hirokazu Mishima, Yuki Namba, Toru Nakai, Masakazu Fujiwara, Toshinaga Tsuji, Chika Sakai
Publikováno v:
Neuropsychiatric Disease and Treatment
Chika Sakai,1 Toshinaga Tsuji,1 Toru Nakai,1 Yuki Namba,1 Hirokazu Mishima,1 Masakazu Fujiwara,2 Hisato Matsunaga3 1Medical Affairs Department, Shionogi & Co. Ltd, Osaka, Japan; 2Data Science Office, Shionogi & Co. Ltd, Osaka, Japan; 3Department of N
Autor:
Ikuko Nakamura, Kiyomitsu Katsumata, Hikaru Mitori, Shinobu Takeda, Satoru Matsumoto, Keisuke Ohsumi, Souichiro Akamatsu, Toru Nakai
Publikováno v:
Antimicrobial Agents and Chemotherapy. 63
Current therapies against invasive pulmonary aspergillosis (IPA) have a limited cure rate. Given that a delay in treatment initiation may be fatal, a new drug with rapid-onset and potent fungicidal activity is needed. The novel cyclic hexapeptide ASP
Autor:
Shinobu Takeda, Takanobu Araki, Souichirou Akamatsu, Katsuyuki Maki, Satoko Uchida, David A. Barrett, Satoru Matsumoto, Kayakiri Natsuko, Toru Nakai, Masaki Tomishima, Hiroshi Morikawa
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 24:1172-1175
The synthesis and antifungal activity of ASP9726, a novel echinocandin with potent Aspergillus hyphal growth inhibition and significantly improved MIC against Candida parapsilosis and echinocandin resistant-Candida is described.
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 71:683-689
症例は81歳,男性.2007年5月黒色便を主訴に来院した.上部消化管内視鏡検査で胃体中部小弯に3型病変を認め,生検で中分化型腺癌であった.腫瘍マーカーは,血清CA19-9値656U/mlと著明な
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 70:891-894
65歳,男性.既往に25歳時に結核性腹膜炎による腹腔内膿瘍,脊椎カリエスで手術.45,55歳時に腸閉塞,結核性腹膜炎による腹腔内膿瘍で手術歴がある.今回,腹痛を主訴に当院内科を
Publikováno v:
Chemotherapy. 54:181-187
Background: Metallo-β-lactamase is one of the feared resistance mechanisms inPseudomonas aeruginosa. Methods: β-Lactamase activity was determined using crude enzymes. Cloned plasmids were transformed in P. aeruginosa KG2505, PAO1 derivative without
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 69:2396-2399
患者は75歳,男性.平成15年7月に他院で腹腔鏡下胆嚢摘出術を施行されている.平成17年5月初旬,右季肋部の発赤が出現し排膿がみられるようになり当科を受診した.腹部所見で手術痕
Publikováno v:
Antimicrobial Agents and Chemotherapy. 51:826-830
FR264205 is a novel parenteral 3′-aminopyrazolium cephalosporin. This study evaluated the in vitro and in vivo activities of FR264205 against Pseudomonas aeruginosa . The MIC of FR264205 at which 90% of 193 clinical isolates of P. aeruginosa were i
Autor:
Noriaki Tanaka, Mary L. Durbin, Yoshio Naomoto, Hirotoshi Tanaka, Yutaka Maeda, Takuya Fukazawa, Toru Nakai, Junji Matsuoka
Publikováno v:
Molecular Cancer Therapeutics. 6:244-252
Gene therapy is one of the approaches used to treat lung cancer. The benefit of cancer gene therapy is that different types of tumors can be selectively targeted by tumor-specific expression of therapeutic genes that include an apoptosis gene to dest